Company News
Back![](https://veralox.com/wp-content/themes/veralox/src/img/woman-patient-16x9.jpg)
Veralox Therapeutics Appoints Lisa Beck as Chief Business Officer
Veralox Therapeutics, a biotechnology company developing first-in-class small molecule therapeutics that treat the underlying pathologies of diseases with significant unmet medical needs, today announced the appointment of Lisa Beck as Chief Business Officer.